EP 607 : Nvidia's $7B Open‑AI Play, SpaceX vs China’s LandSpace, and Moderna’s Cancer Vaccine

From chip giants to rocket pioneers and life‑saving vaccines, today’s episode packs the headlines that will shape the next decade of technology. We kick off with Nvidia’s bold $7 billion “Poolside” deal, a high‑stakes gamble to turn the open‑model AI layer into a U.S. strategic asset. Hear how Jensen Huang plans to out‑maneuver China’s open‑weight contenders and why this move could redefine who controls the AI super‑highway.Next, we shift to the final frontier. China’s private launch firm LandSpace joins the elite club of SpaceX and Blue Origin after successfully landing the first stage of its Zhuque‑3 booster. We break down what a 20‑flight reusable rocket means for launch costs, global competition, and the race to make space travel as routine as air travel.The science spotlight lands on Moderna and Merck’s experimental mRNA cancer vaccine, which in a large human trial kept high‑risk melanoma patients cancer‑free longer when paired with Keytruda. We explore how personalized mRNA is moving from COVID‑19 to oncology, and why this could spark a new wave of tumor‑targeted therapies.We also dive into a prehistoric croc the size of a pickup truck, a massive Chinese flying‑wing jet concept, and the week’s most useful AI productivity tools—from Framer AI Agents that auto‑design websites to Grok Bot’s virtual teammates.Whether you’re a founder, investor, or tech enthusiast, this episode gives you the context and the tools to stay ahead. Hit play, share with your network, and subscribe for more deep‑dive analysis every week.Tools mentioned: Framer AI Agents, Grok Bot, Ito, Tines 3B, Nuphos, Lettertrace.